Cutaneous allodynia prevalence comparable in patients with migraine and probable migraineMarch 12, 2021Headache & Migraine
Acute migraine treatment: Real-world data reaffirm efficacy and safety of ubrogepantMarch 12, 2021Headache & Migraine
Lasmiditan demonstrates superior pain freedom at 2 hours in at least 2 of 3 migraine attacksMarch 5, 2021Headache & Migraine
Acute care of migraine and cluster headaches: Mainstay treatments and emerging strategiesMarch 3, 2021Headache & Migraine
Erenumab improves functional outcomes in patients with episodic migraineFebruary 19, 2021Headache & Migraine
Fewer headache days with erenumab in onabotulinumtoxin A resistant chronic migraineFebruary 19, 2021Headache & Migraine
Migraine linked to more than doubled risk for irritable bowel syndromeFebruary 19, 2021Headache & Migraine
Migraine: Triptan responders are more likely to respond to erenumabFebruary 19, 2021Headache & Migraine
